0000000000040990

AUTHOR

Martin Glaser

showing 12 related works from this author

The Cumulative Effect of Transient Synchrony States on Motor Performance in Parkinson's Disease.

2020

Bursts of beta frequency band activity in the basal ganglia of patients with Parkinson's disease (PD) are associated with impaired motor performance. Here we test in human adults whether small variations in the timing of movement relative to beta bursts have a critical effect on movement velocity and whether the cumulative effects of multiple beta bursts, both locally and across networks, matter.

0301 basic medicineMaleParkinson's diseaseBehavioral/CognitiveParkinson's diseaseDeep Brain StimulationElectroencephalography Phase Synchronization610 Medicine & healthLocal field potentialHypokinesialocal field potentialsBasal Ganglia03 medical and health sciencesBursting0302 clinical medicineSubthalamic NucleusBasal gangliaMedicineHumansBeta (finance)610 Medicine & healthCumulative effectResearch ArticlesAgedCued speechbeta oscillationsbusiness.industryGeneral NeuroscienceParkinson DiseaseMiddle Agedmedicine.diseaseSubthalamic nucleus030104 developmental biologyFemaleCuesbusinessBeta RhythmNeuroscience030217 neurology & neurosurgeryPhotic StimulationPsychomotor Performance
researchProduct

Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.

2006

Summary: Purpose: Although animal data are suggestive, evidence for an alteration of the extrastriatal dopaminergic system in human focal epilepsy is missing. Methods: To quantify D2/D3-receptor density, we studied seven patients with temporal lobe epilepsy (TLE) and nine agematched controls with positron emission tomography (PET) by using the high-affinity dopamine D2/D3-receptor ligand [ 18 F]Fallypride ([ 18 F]FP) suitable for imaging extrastriatal binding. TLE was defined by interictal and ictal video-EEG, magnetic resonance imaging (MRI), and [ 18 F]fluorodeoxyglucose ([ 18 F]FDG)-PET and was due to hippocampal sclerosis (HS), based on histology in all patients. Primary analysis was ba…

AdultMaleFluorine RadioisotopesPyrrolidinesHippocampusHippocampal formationHippocampusFunctional LateralityTemporal lobeAnimal dataFluorodeoxyglucose F18medicineHumansTissue DistributionFluorodeoxyglucoseHippocampal sclerosisBrain MappingSclerosisbusiness.industryReceptors Dopamine D2Receptors Dopamine D3Videotape RecordingElectroencephalographymedicine.diseaseMagnetic Resonance ImagingTemporal Lobenervous systemNeurologyFallyprideEpilepsy Temporal LobePositron-Emission TomographyCardiovascular agentBenzamidesNeurology (clinical)Nuclear medicinebusinessmedicine.drugEpilepsia
researchProduct

Cross-frequency coupling between gamma oscillations and deep brain stimulation frequency in Parkinson's disease.

2020

Abstract The disruption of pathologically enhanced beta oscillations is considered one of the key mechanisms mediating the clinical effects of deep brain stimulation on motor symptoms in Parkinson’s disease. However, a specific modulation of other distinct physiological or pathological oscillatory activities could also play an important role in symptom control and motor function recovery during deep brain stimulation. Finely tuned gamma oscillations have been suggested to be prokinetic in nature, facilitating the preferential processing of physiological neural activity. In this study, we postulate that clinically effective high-frequency stimulation of the subthalamic nucleus imposes cross-…

MaleDeep brain stimulationmedicine.medical_treatmentDeep Brain StimulationStimulationcross-frequency couplingsource analysis610 Medicine & healthArticlePremotor cortexvolume of tissue activatedSubthalamic NucleusCerebellumGamma RhythmNeural PathwaysmedicineGamma RhythmHumans610 Medicine & healthAgedMovement DisordersSupplementary motor areaResting state fMRIChemistryMotor CortexElectroencephalographyParkinson DiseaseMiddle AgedSubthalamic nucleusmedicine.anatomical_structureFemaleNeurology (clinical)gamma oscillationsBeta RhythmNeuroscienceAlgorithmsMotor cortex
researchProduct

The effects of arterial carbon dioxide partial pressure and sevoflurane on capillary venous cerebral blood flow and oxygen saturation during cranioto…

2009

Intraoperative routine monitoring of cerebral blood flow and oxygenation remains a technological challenge. Using the physiological principle of carbon dioxide reactivity of cerebral vasculature, we investigated a recently developed neuromonitoring device (oxygen-to-see, O2C device) for simultaneous measurements of regional cerebral blood flow (rvCBF), blood flow velocity (rvVelo), oxygen saturation (srvO2), and hemoglobin amount (rvHb) at the capillary venous level in patients subjected to craniotomy. METHODS: Twenty-six neurosurgical patients were randomly assigned to anesthesia with 1.4% or 2.0% sevoflurane end-tidal concentration. After craniotomy, a fiberoptic probe was applied on a ma…

AdultMaleMethyl EthersPartial PressureVasodilation610 Medicine & healthSevofluraneSevofluraneCerebral circulation10180 Clinic for NeurosurgeryMonitoring IntraoperativeLaser-Doppler FlowmetrymedicineHumansAgedbusiness.industryVenous bloodBlood flowOxygenationCarbon DioxideCerebral ArteriesMiddle AgedCerebral VeinsCapillariesOxygenAnesthesiology and Pain MedicineBlood pressureCerebral blood flowCerebrovascular CirculationAnesthesiaFemale2703 Anesthesiology and Pain MedicinebusinessCraniotomymedicine.drug
researchProduct

Postoperative rehabilitation after deep brain stimulation surgery for movement disorders.

2018

Deep brain stimulation (DBS) is a highly efficient, evidence-based therapy for a set of neurological and psychiatric conditions and especially movement disorders such as Parkinson's disease, essential tremor and dystonia. Recent developments have improved the DBS technology. However, no unequivocal algorithms for an optimized postoperative care exist so far. The aim of this review is to provide a synopsis of the current clinical practice and to propose guidelines for postoperative and rehabilitative care of patients who undergo DBS. A standardized work-up in the DBS centers adapted to each patient's clinical state and needs is important, including a meticulous evaluation of clinical improve…

0301 basic medicinemedicine.medical_specialtyMovement disordersDeep brain stimulationmedicine.medical_treatmentDeep Brain StimulationDiseaseNeurosurgical Procedures03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPhysiology (medical)MedicineHumansNeurorehabilitationDystoniaPostoperative CareRehabilitationMovement DisordersEssential tremorbusiness.industryPostoperative rehabilitationmedicine.diseaseSensory Systemsnervous system diseasesddc:616.8030104 developmental biologysurgical procedures operativeNeurologyNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
researchProduct

Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease.

2018

L-DOPA is still the most effective pharmacological therapy for the treatment of motor symptoms in Parkinson's disease (PD) almost four decades after it was first used. Deep brain stimulation (DBS) is a safe and highly effective treatment option in patients with PD. Even though a clear understanding of the mechanisms of both treatment methods is yet to be obtained, the combination of both treatments is the most effective standard evidenced-based therapy to date. Recent studies have demonstrated that DBS is a therapy option even in the early course of the disease, when first complications arise despite a rigorous adjustment of the pharmacological treatment. The unique feature of this therapeu…

0301 basic medicineLevodopaParkinson's diseaseDeep brain stimulationglobus pallidus internus (GPi)medicine.medical_treatmentParkinson's diseaseCentral nervous systemStimulationDiseaseReviewlcsh:RC346-42903 medical and health sciencesTherapeutic approach0302 clinical medicinemedicinelevodopadeep brain stimulation (DBS)lcsh:Neurology. Diseases of the nervous systembusiness.industryDopaminergicmedicine.diseasenervous system diseases030104 developmental biologymedicine.anatomical_structureNeurologyNeurology (clinical)businessNeurosciencesubthalamic nucleus (STN)030217 neurology & neurosurgerymedicine.drugFrontiers in neurology
researchProduct

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1

2021

Medulloblastoma is the most common malignant brain tumor in children. Immunotherapy is yet to demonstrate dramatic results in medulloblastoma, one reason being the low rate of mutations creating new antigens in this entity. In tumors with low mutational burden, gene fusions may represent a source of tumor-specific neoantigens. Here, we reviewed the landscape of fusions in medulloblastoma and analyzed their predicted immunogenicity. Furthermore, we described a new in-frame fusion protein identified by RNA-Seq. The fusion involved two genes on chromosome 2 coding for the enhancer of polycomb homolog 2 (EPC2) and GULP PTB domain containing engulfment adaptor 1 (GULP1) respectively. By qRT-PCR …

MedulloblastomafusionCancer Researchmedulloblastoma; EPC2; GULP1; fusionImmunogenicityIn silicoGULP1Neoplasms. Tumors. Oncology. Including cancer and carcinogensBiologymedulloblastomamedicine.diseaseFusion proteinEPC2OncologyAntigenCancer researchmedicineCytotoxic T cellEnhancerRC254-282CD8Cancers
researchProduct

Intraoperative monitoring of cerebral microcirculation and oxygenation--a feasibility study using a novel photo-spectrometric laser-Doppler flowmetry.

2009

The present study assesses the utility of a novel invasive device (O2C-, oxygen-to-see-device) for intraoperative measurement of the cerebral microcirculation. CO2 vasoreactivity during 2 different propofol concentrations was used to investigate changes of capillary venous cerebral blood flow (rvCBF), oxygen saturation (srvO2), and hemoglobin concentration (rvHb) during craniotomy.Thirty-four patients were randomly assigned to a low propofol (4 mg/kg/h) versus a high propofol (6 mg/kg/h) group. A fiberoptic probe was applied on the cortex next to the surgical site. Measurements were performed during lower (35 mm Hg) and higher (45 mm Hg) levels of partial pressure of carbon dioxide (paCO2).…

AdultMalePhotometryHemoglobinsGermanyMonitoring IntraoperativemedicineLaser-Doppler FlowmetryFiber Optic TechnologyHumansCerebral microcirculationPropofolAgedDose-Response Relationship Drugbusiness.industryOxygen metabolismMicrocirculationSpectrum AnalysisBrainOxygenationLaser Doppler velocimetryCarbon DioxideMiddle AgedOxygenAnesthesiology and Pain MedicineAnesthesiaFeasibility StudiesSurgeryFemaleNeurology (clinical)PropofolbusinessAnesthetics IntravenousBlood Flow VelocityCraniotomymedicine.drugJournal of neurosurgical anesthesiology
researchProduct

Alterations in White Matter Network and Microstructural Integrity Differentiate Parkinson’s Disease Patients and Healthy Subjects

2019

Parkinson’s disease (PD) is a neurodegenerative disease, neuropathologically characterized by progressive loss of neurons in distinct brain areas. We hypothesize that quantifiable network alterations are caused by neurodegeneration. The primary motivation of this study was to assess the specific network alterations in PD patients that are distinct but appear in conjunction with physiological aging. 178 subjects (130 females) stratified into PD patients, young, middle-aged and elderly healthy controls (age- and sex-matched with PD patients), were analyzed using 3D-T1 magnetization-prepared rapid gradient-echo (MPRAGE) and diffusion weighted images acquired in 3T MRI scanner. Diffusion modeli…

0301 basic medicineParkinson's diseaseCognitive NeuroscienceSpleniumCorpus callosumcomputer.software_genrelcsh:RC321-571White matterdiffusion MRI03 medical and health sciences0302 clinical medicineVoxelMedicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal Researchbusiness.industryagingmedicine.diseasenetwork connectivity analysis030104 developmental biologymedicine.anatomical_structureCorticospinal tractParkinson’s diseasebusinessNeuroscienceInsulacomputerwhite matter030217 neurology & neurosurgeryNeuroscienceDiffusion MRIFrontiers in Aging Neuroscience
researchProduct

Cortical network fingerprints predict deep brain stimulation outcome in dystonia.

2018

AbstractBackgroundDeep brain stimulation (DBS) is an effective evidence-based therapy for dystonia. However, no unequivocal predictors of therapy responses exist. We investigate whether patients optimally responding to DBS present distinct brain network organization and structural patterns.MethodsBased on a German multicentre cohort of eighty-two dystonia patients with segmental and generalized dystonia, who received DBS implantation in the globus pallidus internus patients were classified based on the clinical response 36 months after DBS, as superior-outcome group or moderate-outcome group, as above or below 70% motor improvement, respectively. Fifty-one patients met MRI-quality and treat…

0301 basic medicineAdultMaleTreatment responsemedicine.medical_specialtyDeep brain stimulationMovement disordersmedicine.medical_treatmentDeep Brain Stimulation610 MedizinStimulationGrey matterGlobus PallidusSeverity of Illness IndexCohort Studies03 medical and health sciences0302 clinical medicineText miningPhysical medicine and rehabilitationAtrophy610 Medical sciencesmedicineHumansddc:610Dystoniabusiness.industryStructural integrityMiddle Agedmedicine.diseasenervous system diseasesDystoniamedicine.anatomical_structure030104 developmental biologyNeurologyCortical networkDystonic DisordersCohortFemaleNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryMovement disorders : official journal of the Movement Disorder SocietyReferences
researchProduct

Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoin…

2022

Objective Published reports on directional deep brain stimulation (DBS) have been limited to small, single-center investigations. Therapeutic window (TW) is used to describe the range of stimulation amplitudes achieving symptom relief without side effects. This crossover study performed a randomized double-blind assessment of TW for directional and omnidirectional DBS in a large cohort of patients implanted with a DBS system in the subthalamic nucleus for Parkinson's disease. Materials and methods Participants received omnidirectional stimulation for the first three months after initial study programming, followed by directional DBS for the following three months. The primary endpoint was a…

MaleDeep brain stimulationParkinson's diseasemedicine.medical_treatmentParkinson's diseaseDeep Brain StimulationStimulation03 medical and health sciences0302 clinical medicinemedicineClinical endpointHumanstherapeutic windowNeurostimulationTherapeutic windowCross-Over Studiesbusiness.industrydirectional programmingParkinson DiseaseGeneral Medicinemedicine.diseaseCrossover studySubthalamic nucleusAnesthesiology and Pain MedicineTreatment OutcomeNeurologyAnesthesiaQuality of LifeFemaleNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Neuronavigation and epilepsy surgery

2010

Resective epilepsy surgery is an elective therapy indicated in focal epilepsy patients who are resistant to pharmacotherapy. Every effort should be undertaken to perform the procedures as safe and less traumatic as possible. Neuronavigation could represent a suitable tool to reduce surgical morbidity and increase surgical radicality. Here, we present a series of 41 patients who were operated on for medically intractable epilepsy using neuronavigation. Overall, complication rate was 17% with a favourable seizure outcome of 88% (Engel’s class I/II). Our data suggest that neuronavigation is a valuable surgical technique to accomplish a favourable outcome in epilepsy surgery.

medicine.medical_specialtyNeuronavigationbusiness.industryMedically intractable epilepsySeizure outcomemedicine.diseaseSurgerySurgical morbidityEpilepsyPharmacotherapyMedicineComplication rateEpilepsy surgerybusinessHealth
researchProduct